4//SEC Filing
Heberlig Chris 4
Accession 0001104659-18-058108
CIK 0001730430other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 8:58 AM ET
Size
5.4 KB
Accession
0001104659-18-058108
Insider Transaction Report
Form 4
Heberlig Chris
Exec VP & CFO10% Owner
Transactions
- Award
Share Option
2018-09-20+45,000→ 45,000 totalExercise: $30.93Exp: 2028-09-19→ Class A Common Shares (45,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three-year period thereafter. The vesting commencement date is September 20, 2018.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001532217
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 8:58 AM ET
- Size
- 5.4 KB